Ire1 is an ancient transmembrane sensor of ER stress with dual protein kinase and ribonuclease activities. In response to ER stress, Ire1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. We have determined the crystal structure of the dual catalytic region of Ire1at 2.4 Å resolution, revealing the fusion of a domain, which we term the KEN domain, to the protein kinase domain. Dimerization of the kinase domain composes a large catalytic surface on the KEN domain which carries out ribonuclease function. We further show that signal induced trans-autophosphorylation of the kinase domain permits unfettered binding of nucleotide, which in turn promotes dimerization to compose the ribonuclease active site. Comparison of Ire1 to a topologically disparate ribonuclease reveals the convergent evolution of their catalytic mechanism. These findings provide a basis for understanding the mechanism of action of RNaseL and other pseudokinases, which represent 10% of the human kinome.
INTRODUCTION
Endoplasmic reticulum (ER) stress is characterized by the accumulation of toxic misfolded protein aggregates in the ER lumen (Bernales et al., 2006; Ron and Walter, 2007) . Ire1 is an evolutionarily conserved, ER stress sensor present in all eukaryotes with both protein kinase and ribonuclease activities (Sidrauski and Walter, 1997) . These activities are critical for the induction of the Unfolded Protein Response (UPR), a complex set of homeostatic mechanisms evolved to cope with ER stress in eukaryotes by promoting protein folding and maturation in the ER (Bernales et al., 2006; Ron and Walter, 2007) .
Ire1 detects elevated unfolded protein levels in the ER and transmits a signal to the nucleus by splicing mRNAs encoding master transcriptional regulators of the UPR response-Hac1p in yeast and Xbp1 in metazoans-independent of the spliceosome (Calfon et al., 2002; Lee et al., 2002; Sidrauski and Walter, 1997; Yoshida et al., 2001 ). Ire1 cleaves a single phosphodiester bond in each of two RNA hairpins (with nonspecific base-paired stems and loops of consensus sequence CNCNNGN, where N is any base) (Gonzalez et al., 1999) to remove an intervening intron from target transcripts. A second enzyme, the yeast tRNA ligase Rlg1, joins the adjacent exons to generate a mature transcript (Gonzalez et al., 1999; Sidrauski et al., 1996) (the metazoan homolog of Rlg1 has yet to be identified). Removal of the intron introduces a frame shift that yields a functional activator of the UPR (Calfon et al., 2002; Lee et al., 2002; Mori, 2003; Sidrauski and Walter, 1997; Yoshida et al., 2001) . The mature forms of Xbp1 and Hac1 execute the UPR transcription program to upregulate the expression of a multitude of gene products including ER-resident proteins that promote protein folding and maturation and ER-associated proteins involved in protein degradation (Travers et al., 2000) .
Ire1 is a type I transmembrane receptor consisting of an N-terminal ER luminal domain, a transmembrane segment and a cytoplasmic region. The cytoplasmic region of Ire1 encompasses a protein kinase domain followed by a C-terminal extension of $150 residues. The X-ray crystal structure of the luminal domain of yeast and human Ire1 have been determined (Credle et al., 2005; Zhou et al., 2006) , shedding light into signal-dependent dimerization/oligomerization of the receptor. No structural information has been forthcoming for the cytoplasmic/enzymatic portion of the protein. The cytoplasmic region of Ire1 contains its catalytic activities and is related to the antiviral ribonuclease RNaseL, which is thought to share a common ribonuclease mechanism. Unlike Ire1, RNaseL lacks protein kinase activity and cleaves single-stranded RNA to inhibit protein synthesis in response to viral stress (Floyd-Smith et al., 1981) . While kinase activity seems expendable in the ribonuclease mechanism of RNaseL, and by inference that of Ire1, the structural integrity of the kinase domains of both Ire1 and RNaseL are, paradoxically, essential for their ribonuclease functions. Incidentally, neither Ire1 nor RNaseL display sequence similarity to known nucleases.
Structural and biophysical characterization of the luminal domain of human and yeast Ire1 supports the notion that Ire1 has Structure-based sequence alignment of the protein kinase domain and KEN (Kinase Extension Nuclease) domain of Ire1 sequences from S. cerevisiae (yeast), H. sapiens (human), M. musculus (mouse), R. norvegicus (rat), G. gallus (chicken), X. laevis (frog), D. melanogaster (fruitfly), A. mellifera (honey bee), C. elegans (nematode), A. thaliana (mouse-ear cress), and O. sativa (rice); and RNase L sequences from H. sapiens (human), P. pygmaeus (orangutan), M. musculus (mouse), a propensity to dimerize upon exposure to unfolded protein in the ER lumen. In analogy to many transmembrane receptor kinases, the signal induced dimerization/oligomerization of human and yeast Ire1 in the plane of a membrane is thought to promote trans-phosphorylation on positive regulatory sites within the protein kinase domain (minimally Ser 840 and Ser 841 in yeast Ire1) by juxtaposing two kinase domains in close proximity and thus to induce its cytoplasmic kinase activity (Shamu and Walter, 1996; Welihinda and Kaufman, 1996) .
In addition to effecting a change in its protein kinase catalytic function, dimerization and autophosphorylation of Ire1 lead to the activation of its ribonuclease activity (Sidrauski and Walter, 1997) . Interestingly, the ribonuclease function of Ire1 is also greatly potentiated in vitro by the binding of nucleotide (either ADP or ATP and its nonhydrolysable analogs, with ADP having the greatest effect) (Sidrauski and Walter, 1997) presumably to the kinase domain active site. The mechanism by which receptor dimerization, kinase domain autophosphorylation and nucleotide binding regulate ribonuclease function remains an open question. In addition, the absence of similarity between Ire1 and any previously characterized ribonuclease enzyme leaves the basis by which Ire1 (and by extension RNaseL) binds and cleaves RNA a complete mystery.
To gain mechanistic insight into the basis of RNA cleavage by Ire1 and the regulatory link between its ribonuclease and protein kinases catalytic functions, we have solved the 2.4 Å X-ray crystal structure of a cytoplasmic region of Ire1 encompassing the protein kinase domain and C-terminal kinase extension. Together with mutational and functional analyses on Ire1 performed in vitro and in vivo, these studies further our understanding of how Ire1 transduces a signal across the ER membrane in response to the detection of unfolded protein in the ER lumen.
RESULTS
A survey of N-and C-terminal boundaries uncovered a minimal cytosolic fragment of yeast Ire1 (residues 658-1115), denoted Ire1 cyto , that expressed well in bacteria as a TEV protease cleavable polyhistidine tag fusion, and that displayed regulatory and catalytic properties of the full-length protein (Cox et al., 1993; Mori et al., 1993; Sidrauski and Walter, 1997) . Ire1 cyto is active as a protein kinase as evidenced by its steady-state phosphorylation status following purification from E. coli lysates (see change in electrophoretic mobility following phosphatase treatment in Figure S1A available online) and its ability to autophosphorylate in an enzyme concentration-dependent manner in the presence of g-[
32 P]-ATP ( Figure S1B ). Mass spectroscopy analysis revealed stoichiometric phosphorylation on two previously characterized regulatory sites (Ser840 and Ser841) (Shamu and Walter, 1996) and two sites with no known regulatory function (Thr844, and Ser850) within its activation segment ( Figure S1C ). Mutation of Thr844 but not Ser850 severely impaired Ire1 function in vivo, as observed for mutation of Ser841 and to a lesser degree Ser840 ( Figure S1D Table S1 . A representative region of experimentally phased electron density is shown in Figure S5A . A structure-based sequence alignment of the protein kinase domain and conserved C-terminal extension of Ire1, and for comparison RNaseL, is shown in Figure 1 . Ribbon representations of the Ire1 structure are shown in Fig Each Ire1 protomer (i.e., half of the dimer) consists of an N-terminal kinase-domain followed by a 132 residue globular domain formed by the conserved C-terminal kinase extension. We have termed the latter domain the kinase-extension nuclease (KEN) domain for reasons explained later in this study. The kinase domain possesses a prototypical bilobal fold with a smaller N-terminal lobe (N-lobe) and a larger C-terminal lobe (C-lobe). The N-lobe (residues 673 to 748) consists of a twisted 5-strand anti-parallel b sheet (denoted b1 to b5) and a laterally flanking helix aC ( Figure S5B ). The C-lobe (residues 749-982) is comprised of two paired antiparallel b strands (b7-b10 and b8-b9) and 11 a helices (aD to aL). Positioned between b strand 10 R. norvegicus (rat), and C. familiarus (dog). Residues invariant across the Ire1-RNaseL family of kinase-ribonucleases are highlighted in blue, while residues invariant or highly conserved specifically in Ire1 are colored in green and yellow, respectively. The secondary structure of S. cerevisiae Ire1 is indicated above the alignment using the coloring scheme of Protomer 1 in Figure 2A . A conserved disordered region in the KEN domain termed ''Putative RNA specificity determinants'' is delineated by a black-box. The kinase domain activation segment of Ire1 is indicated by a set of black arrows. Dashed lines represent unmodeled disordered regions of the crystal structure. and helix aEF (and corresponding to residues 828-859) is the activation segment, which serves a phosphoregulatory function in many protein kinases including Ire1 (Nolen et al., 2004) . In the Ire1 cytoD24 crystal structure, a major portion of the activation segment (residues 836-852) is disordered. We interpret this to reflect the dynamic nature of the activation segment in its phosphorylated productive state. Lastly, Ire1 possesses a noncanonical helix, denoted aE', inserted between b strands b8 and b9 of the C-lobe. This helix resides on the back-side of the protein kinase domain where it participates in dimer formation (discussed below). Visible within the interlobe cleft of each Ire1 cytoD24 protomer is a fully resolved ADP molecule ( Figure S5A ). The binding of ADP gives rise to a closed conformation of the bi-lobal kinase domain compatible with the phosphor-transfer mechanism. Indeed, all invariant active site residues among protein kinases that play a role in nucleotide binding or in the phosphotransfer mechanism are positioned in a productive manner ( Figure S5B ) (reviewed in (Huse and Kuriyan, 2002) ). Extending immediately from the C-lobe of the kinase domain is the KEN domain. The disposition of the KEN domain on the opposite face of the kinase domain C-lobe, relative to the N-lobe, gives rise to an elongated trilobal structure ( Figure 2A ). As assessed by Dali (Holm and Sander, 1995) and VAST (Madej et al., 1995) , the eight a helices (denoted a1-a8, Figure 2C ) of the KEN domain comprise a novel fold. Within this fold, only a six residue conserved sequence (Asn1036-Arg1041) between helices a3 and a4 is disordered. The hydrophobic nature of the inter domain contact surfaces appears to enforce a fixed orientation between the KEN domain and the C-lobe of the kinase domain and a co-dependence for proper folding ( Figure 2B ). This might explain our inability to express stable forms of the individual KEN and kinase domains (data not shown). Sequence conservation across Ire1 and RNaseL orthologs suggests that the KEN domain structure and its relative orientation to the adjacent kinase domain will be shared by RNaseL (Figure 1 ).
Dimerization of Ire1
Ire1 cytoD24 adopts a parallel back to back dimer configuration related by a noncrystallographic 2-fold rotation about the long axis of the protomer. The larger of two discontinuous dimerization surfaces is composed by the kinase domain ( Figure 2A ) and buries a total of 2400 Å 2 of area. Residues on this surface include N672, F694, R697, T720, D723, R730, Y731, S783, H787, R810, D814, and Q816 (Figure 1 and 2D ). Residues projecting from the N-lobe (specifically b strands b2, b3, b4, and helix aC) are well conserved across Ire1 orthologs, while those from the C-lobe, (projecting from the nonconical helix aE' and its flanking linker sequences) appear specific to yeast Ire1.
Comparison of the Ire1 cytoD24 structure to previously determined protein kinase domain structures reveals great similarity to the dimer configurations of the eIF2a protein kinase PKR (RMSD = 3.72 Å ) ( Figure S5C ) and the Mycobacterium tuberculosis protein kinases PknB, and PknE (Gay et al., 2006; OrtizLombardia et al., 2003; Young et al., 2003) . Since signal induced dimerization of PKR (Dey et al., 2005) and the Pkn family kinases (Greenstein et al., 2007) serves to allostrerically regulate their kinase activities, this similarity raises the possibility of a similar role for dimerization in regulating Ire1 protein kinase function. The second noncontiguous dimerization surface of Ire1 cytoD24 , is composed entirely by the KEN domain ( Figure 2A ). Residues on gives rise to an extensive concave surface on the bottom of the KEN domain. This surface represents the most conserved region of the whole Ire1 cytoD24 dimer structure ( Figure 3A ). Within the ordered part of this surface reside three highly conserved residues (D995, E998, R1053) and four invariant residues (Y1043, R1056, N1057 and H1061) ( Figure 3B ). Within the disordered part of the surface, consisting of a six residue linker connecting helices a3 and a4, reside five highly conserved residues (N1036, L1037, R1039, Y1040, and R1041) ( Figure 3B ). Based on (1) the pocket-like nature of this surface, (2) the observation that four ordered residues, namely Y1043, R1056, N1057, and H1061, are invariant across the larger Ire1/RNaseL ribonuclease family (which likely share a common ribonuclease catalytic mechanism) (Figures 1 and 3B ) and (3) the observation that R1056 and H1061 in Ire1 (R667 and H672 in human RNaseL) are essential for ribonuclease function (Dong et al., 2001) , we reason that this surface comprises the ribonuclease active site of Ire1. We test this hypothesis experimentally below.
Mutational Analysis of the Ire1 Dimer Contact Surfaces
Based on the similarity of the dimer configuration of Ire1 cytoD24 to the kinase domain structures of PKR and PknB/E, we reasoned that the observed mode of Ire1 dimerization might play an essential role in regulating protein kinase activity. Alternatively, based on the possibility that the ribonuclease active site of Ire1 resides within a composite surface spanning two KEN domains, we reasoned that the Ire1 cytoD24 dimer configuration might play an essential role in regulating ribonuclease function. To test these models, we introduced site-specific mutations at dimer interface positions of Ire1 cyto and tested in vitro ribonuclease and protein kinase functions of recombinant mutant proteins expressed in bacteria.
Wild-type Ire1 cyto cleaved Xbp1 mini , yielding the expected products ( Figure 4A ). In contrast, alanine substitution of kinase domain dimer interface residues R697, D723, and R730 (Figure 2D ) or charge reversal mutations R697D, D723R, R730D, greatly perturbed ribonuclease function ( Figure 4A ). Similarly, KEN domain dimer interface mutations including E988Q, K992D, and Y1059A ( Figure 2E ), greatly compromised the ability to cleave Xbp1 mini . In contrast to the potent effect on ribonuclease function, none of the aforementioned dimer interface mutations perturbed protein kinase catalytic function ( Figures S2A,  S2B , and S2E). Together these results indicate that, in stark contrast to PKR, residues comprising the kinase domain and KEN domain dimer interfaces are essential for the ribonuclease but not the protein kinase function of Ire1. We next tested whether the double-charge reversal mutations R697D/D723R and D723R/R730D, could restore ribonuclease function by reconstituting a dimer spanning salt-bridge in Ire1 cyto ( Figure 4A, bottom panel) . As shown in Figure 4A , both R697D/ D723R and D723R/R730D double-mutant proteins displayed partial (two-fold) improvement in ribonuclease function relative to the most perturbing single-site mutant proteins (i.e., R697D and R730D, respectively). These results strongly support the notion that the specific dimer configuration of Ire1 cytoD24 observed in the crystal structure is critically important for the ribonuclease function of Ire1.
Consistent with a requirement of the kinase domain dimer interface residues R697, D723, and D730 for ribonuclease function, charge reversal mutations at these positions inactivated yeast Ire1 in vivo without affecting protein levels ( Figure 4B , compare vector and WT lanes). In addition, these kinase domain dimer interface mutations blocked the tunicamycin-induced activation of a lacZ reporter gene under the control of a UPR element from the yeast KAR2 gene ( Figure S6 ). In contrast to the partial restoration of ribonuclease activity observed in vitro, combining the R697D and D723R or the D723R and R730D mutations failed to rescue growth on medium containing tunicamycin or activation of the tunicamycin-inducible lacZ reporter ( Figures 4B and S6 ). These data indicate that the salt bridge interactions spanning the kinase domain dimer interface are necessary for Ire1 function in vivo. The inability of yeast expressing the double-charge reversal Ire1 mutants to grow on medium containing tunicamycin may indicate that the partial restoration of ribonuclease activity provided by combining these mutations is below the threshold level required for yeast cell growth.
Mutational Analysis of the Candidate Ribonuclease Active Site
To assess the importance of residues within the candidate ribonuclease active site of Ire1 cyto , we introduced site specific mutations into Ire1 cyto and tested the mutant recombinant proteins for function as for the dimer interface mutants described above. We first investigated conserved residues on the ordered portion of the KEN domain surface ( Figure 3B ). We found that the D995A, Y1043A, R1053E, R1056A, N1057A, and H1061A mutant proteins displayed a complete loss of RNA cleavage function ( Figure 5A , upper panel), without an apparent loss of protein kinase function ( Figures S2C and S2E ). We next investigated conserved residues within a disordered loop connecting KEN domain helices a3 and a4 ( Figure 3B ). We found that the L1037A, R1039A, Y1040A, and R1041A, but not N1036A mutant proteins, were greatly deficient for ribonuclease function (Figures 5A and 5B) but not protein kinase function ( Figure S2D ). As was observed with the kinase domain interface mutants, the ribonuclease active site mutants blocked Ire1 function in yeast. Mutation of both the ordered and the disordered ribonuclease active site residues abrogated Ire1 function in yeast ( Figures 5B and  S7) . Together, our in vitro and in vivo mutational results provide compelling support to the notion that the concave surface on the KEN domain embodies the ribonuclease active site of Ire1.
ADP Binding Promotes Ire1
cyto Dimerization Our structural and functional studies thus far indicate that as a ribonuclease, Ire1 functions as a dimer. To investigate the oligomerization state of Ire1 cyto in solution, we performed analytical ultracentrifugation. In its apo form, Ire1 cyto behaves as a homogeneous monomer in solution over all protein concentrations tested (6.1-24.6 mM) ( Figure S8 ). In contrast, the solution behavior of Ire1 cyto transitions to a monomer-dimer equilibrium in the presence of ADP with an approximate dissociation constant of 298 mM. Since nucleotide potentiates the ribonuclease activity of Ire1, we reason that this phenomenon might reflect the ability of ADP to promote the specific dimer configuration of Ire1 cyto we observe in the X-ray crystal structure. Figure 6 ). From this data, we conclude that autophosphorylation, presumably on regulatory sites within the activation segment, serves to regulate access of the kinase domain active site to nucleotide binding.
Ribonuclease Catalytic Mechanism of Ire1
Our studies thus far have identified 10 of 458 residues in the minimal catalytic region of Ire1 that are surface exposed, highly conserved, clustered in space, and required for the ribonucleolytic activity. Based on the likelihood that Ire1 and RNaseL share a common RNA cleavage mechanism, we reasoned that the residues directly involved in catalysis must be common to both enzymes. Only four residues in the Ire1 nuclease active site fulfill this requirement, namely Y1043, R1056, N1057, and H1061. We next assessed whether this group of four residues in Ire1 bears geometric and chemical similarity to the catalytic residues in any of the 12 nonredundant ribonuclease folds represented in the protein data bank. Within this group of ribonucleases, the tRNA splicing endonuclease (PDB ID = 2GJW) displays a similar composition of catalytic residues, (Y246, S258, H257, K287) to the residues we identified for Ire1, despite a complete lack of similarity in their three-dimensional folds (Figure 7) . Superposition of the catalytic residues in the tRNA endonuclease and Ire1 crystal (Kimata et al., 2004) , were separated by SDS-PAGE and then immunoblotted using monoclonal anti-FLAG antibodies (Sigma).
structures reveals striking correspondence in both the chemical nature and spatial disposition of functional groups ( Figure 7A , bottom panel), which allows us to infer the specific role of each of the four residues in the Ire1 catalytic cluster. As shown in Figure 7A (bottom panel), the imidazolium ring of Ire1 H1061 aligns well with that of tRNA endonuclease H257, which serves as a general acid to protonate the 5 0 -OH leaving group (Xue et al., 2006) . The sidechain amide nitrogen of N1057 in Ire1 aligns well with the backbone amide nitrogen of tRNA endonuclease S258, which positions the scissile phosphate for nucleophilic attack. The guanidinium group of Ire1 R1056 and the amino group of the tRNA endonuclease K287, which stabilizes the negatively charged transition state, are similarly disposed. Only the hydroxyl group of Y1043 is shifted 5 Å from its expected postion relative to Y246 in tRNA endonuclease. Given that Y1043 resides within a flexible region of Ire1, we reason that Y1043 reorients to the position occupied by tRNA endonuclease Y246 to enable catalysis. Such a repositioning might occur as a result of Ire1 binding to RNA substrates. Consistent with the notion that Ire1 employs the same catalytic mechanism as tRNA endonuclease and other 2 0 -3 0 cyclizing ribonucleases, wherein the 2 0 -OH group adjacent to the scissile phosphate plays a critical role in catalysis, substitution of the conserved guanosine 5 0 to the scissile phosphate with deoxyguanosine completely abolishes cleavage of single hairpin substrates by Ire1 ( Figure S4B ). Furthermore, Ire1 has also been reported to generate products bearing 2 0 -3 0 cyclic phosphate termini (Gonzalez et al., 1999) .
DISCUSSION

Model of Ire1 Regulation
Our results provide a basis for understanding how the protein kinase and ribonuclease activities of Ire1 are regulated and how the two distinct structural domains responsible for each activity are functionally interconnected ( Figure 7B ). In its resting state, Ire1 resides in a monomeric form, in part because the cytoplasmic and the ER luminal regions of the transmembrane receptor lack a strong ability to dimerize or are prevented from dimerizing in the absence of unfolded protein. In response to the accumulation of unfolded protein in the ER, the luminal domain of Ire1 tightly dimerizes (possibly oligomerizes) promoting the juxtaposition of two cytoplasmic kinase domains in a face to face manner that facilitates trans-autophosphorylation on regulatory sites within the activation segment. This posttranslational modification provides unfettered access of the kinase domain to the binding of nucleotide which in turn enables a back-to-back dimer configuration involving discontinuous surfaces on the protein kinase and KEN domains. This mode of dimerization generates a large two fold symmetric catalytic surface on the base of the KEN domain that is fully competent for ribonuclease function.
Regulation of Ribonuclease Function by Nucleotide Binding
Protein kinase domains possess a bilobal architecture characterized by great interlobe flexibility (Huse and Kuriyan, 2002 ) that facilitates the exchange of ADP and phosphoprotein products with ATP and protein reactants. As evidenced by crystallographic studies, the binding of nucleotide (ATP/ADP) to the catalytic cleft of protein kinase domains favors the adoption of a well defined closed conformation compatible with the phosphor-transfer mechanism (Huse and Kuriyan, 2002) . In the Ire1 cyto crystal structure, this same closed nucleotide bound conformation of the kinase domain appears conducive to dimer formation. Indeed, we show that ADP binding actually promotes the ability of Ire1 cyto to form dimers in solution. Based on these observations, we reason that nucleotide binding stabilizes dimer formation by limiting the kinase domain from sampling alternate interlobe conformations that are incompatible with dimer formation. Since the degree of lobe closure is very similar for kinase domains when bound to ATP or ADP, this could explain why both molecules (and also nonhydrolysable analogs of ATP) can potentiate ribonuclease function (Sidrauski and Walter, 1997) . We were able to reproduce the observation that ADP is a more potent stimulator than ATP (Sidrauski and Walter, 1997) . If this reflects tighter binding of ADP versus ATP, we speculate that the presence of the gamma phosphate moiety to ATP creates greater electrostatic repulsion between the quadruplely phosphorylated A-loop than generated by ADP, and as a consequence lowers the binding affinity of ATP. This is manifested in the differential effect of ADP versus ATP on Ire1 ribonuclease function ( Figure S3D and [Sidrauski and Walter, 1997] ).
Regulation of Ribonuclease Activity by the Activation Segment
The phosphorylation status of Ire1 affects its ability to bind nucleotide and nucleotide binding in turn promotes the ability of Ire1 to dimerize. By analogy to the insulin receptor kinase (Hubbard et al., 1994) , we reason that the activation segment in its dephosphorylated state engages the active site of the kinase domain to inhibit nucleotide binding. This might occur in a manner that locks the two kinase lobes in a fixed orientation that is incompatible with dimerization or in a manner that accentuates interlobe flexibility. The latter might provide an entropic impediment to dimerization.
Interestingly, Papa et al. (2003) demonstrated that the binding of the protein kinase inhibitor 1NM-PP1 to analog sensitive forms of Ire1 had the effect of activating rather than inhibiting the downstream UPR signaling response. From this result, we reason that the 1NM-PP1 inhibitor must bind to the kinase domain of Ire1 in a manner that enforces a closed conformation of the kinase domain similar to the ATP/ADP bound state and thus promotes dimerization to activate ribonuclease function. If true, this raises the possibility that other kinase domain targeting inhibitors of Ire1 that enforce dimer-incompatible closure of the kinase domain might serve to inhibit Ire1 ribonuclease function.
Presumably, the binding mode of 1NM-PP1 to Ire1 is sufficiently different from ADP that it is insensitive to the phosphorylation status of the activation segment and hence bypasses the need for autophosphorylation. Alternatively 1NM-PP1 might bind to Ire1 with sufficient affinity that it competitively displaces any inhibitory conformation of the activation segment.
Regulation of Ribonuclease Function by Dimerization
The requirement of dimerization for Ire1 ribonuclease function suggests that certain functional determinants are supplied in trans from opposing protomers. Consistent with the notion that the core catalytic tetrad defining each ribonuclease active site is constituted in cis ( Figure 7A ), mixing of active site mutants did not restore nuclease activity ( Figure S9 ). We surmise that the functional component supplied in trans is represented by the substrate recognition infrastructure, which may be provided wholly or in part by opposing protomers in trans. Alternatively, if all functional determinants are self-contained within each protomer of Ire1, we surmise that dimerization serves to regulate each catalytic center through an allosteric mechanism.
Implications of Twinned Catalytic Centers in the Ire1 Nuclease Active Site The Ire1 crystal structure reveals two catalytic centers symmetrically arrayed on adjacent KEN domains. Since the RNA hairpins recognized by Ire1 are paired in its physiological substrates (Mori, 2003) , we reason that Ire1 may engage two hairpins cooperatively, perhaps as a mean to increase the affinity and specificity of the interaction. Indeed, this might explain why tandem hairpin substrates are more efficiently cleaved than single hairpin substrates (Gonzalez et al., 1999) .
Since the two ribonuclease catalytic centers in the Ire1 dimer are related by two-fold rotation symmetry, we reason that cooperative substrate recognition may be achieved when the two hairpins in transcripts recognized by Ire1 are pre-ordered in a two-fold symmetric structure. Consistent with this possibility, the loop sequences of target hairpins are pseudo-palindromic and display striking potential to base pair when aligned in a staggered anti-parallel manner ( Figure S10A ). This pattern is reminiscent of kissing hairpin structures, which contain dyad symmetry ( Figure S10B ). An interesting feature of the kissing hairpin model is that it places the projected cleavage sites within adjacent hairpins in the same approximate distance of separation as the two catalytic centers of the KEN domain dimer (11.5 Å in RNA model versus 13.5 Å in KEN domain dimer). Close correspondence in the distance of separation between twinned RNA cleavage sites and twinned catalytic centers appears to be a requisite for substrate recognition by tRNA endonuclease ( Figure S10B and Xue et al., 2006) . Further understanding of Ire1's ribonuclease catalytic mechanism and the structural features of its RNA substrates that mediate recognition awaits the structure of Ire1 in complex with RNA.
Relevance to RNaseL
Ire1 and RNaseL compose a unique subfamily of proteins possessing a recognizable protein kinase domain and ribonuclease activity. The latter is attributable to the presence of the KEN domain in both proteins. The ribonuclease activity of both enzymes are regulated by dimerization, and potentiated by nucleotide binding (Credle et al., 2005; Dong et al., 1994; Sidrauski and Walter, 1997; Zhou et al., 2006) . We anticipate that RNaseL will also adopt the same back-to-back dimer conformation in its active state. Similarly, we anticipate that nucleotide binding to the kinase domain of RNaseL promotes dimerization and hence ribonuclease activity through a common mechanism.
Unlike Ire1, RNaseL lacks protein kinase catalytic function and does not require autophosphorylation for the activation of its ribonuclease function (Dong et al., 1994) . Based on sequence alignments (Figure 1 ), this might be explained by the complete absence of an activation segment in RNaseL. In contrast to Ire1, the absence of an activation segment would provide constitutive access of the kinase domain active site to nucleotide binding. Thus, the primary mode of regulation for RNaseL would lie at the level of dimerization which is promoted by the binding of virus induced second messengers, namely 2 0 -5 0 oligo-adenylate polymers, to the N-terminal ankyrin repeat domain of RNaseL (Dong and Silverman, 1995) .
RNaseL targets a distinct class of RNA substrates from those targeted by Ire1, cleaving singled stranded regions in both coding and noncoding RNAs (Floyd-Smith et al., 1981) . We surmise that differences in substrate preferences between Ire1 and RNaseL are attributable in part to a disordered region connecting helices a3 and a4 in the KEN domain, whose sequence is unqiuely conserved in each group of enzymes (Figure 1 ). Consistent with this possibility, we showed that the residues in the disordered region of Ire1 are essential for its ribonuclease function.
Comparison to PKR and Relevance for Pseudokinases
Despite close phylogenetic descent and similarity in the back-toback dimer configuration adopted by Ire1 and PKR, the effect of dimerization on protein function is radically divergent. In the case of PKR, kinase domain dimerization allosterically upregulates phosphotransfer activity; in the case of Ire1, dimerization of the kinase domain simply serves as a scaffold to bring two adjacent KEN domains into a precise register that has no bearing on kinase activity. In the extreme case of the pseudo-kinase RNaseL, the kinase domain of RNaseL has completely lost phosphotransfer function. In this regard, the structure of Ire1 cyto provides a basis for understanding the mechanism of action of other pseudo-kinases which represent 10% of the 518 protein kinases encoded in the human genome (Boudeau et al., 2006) . Recent studies have demonstrated frequent mutation of Ire1 in human cancer genomes (Greenman et al., 2007) as well as the direct involvement of the downstream target of Ire1, namely Xbp1, in the development of multiple myeloma (Carrasco et al., 2007) . The work presented here provides a framework for dissecting the potentially complex relationship between Ire1 function and its role in disease such as cancer. Furthermore, this work sheds light on potential therapeutic avenues for the positive and negative manipulation of Ire1 signaling function. Schneider and Sheldrick, 2002) was used to locate all 12 selenium sites. Phase extensions were performed with SHELX E (Debreczeni et al., 2003) . Density modification and automated model building was performed using RESOLVE (Terwilliger, 2003) . The final model was generated using a combination of manual adjustment (COOT [Emsley and Cowtan, 2004] ) and model refinement (REFMAC5 [Vagin et al., 2004] ) to a final resolution of 2.4 Å with R work = 23.8% and R free = 27.2%.
In Vitro lPPase and RNA Cleavage Assays The phosphorylation status of purified Ire1 proteins was assessed by incubation of ten-fold molar excess of Ire1 with lPPase in the presence of 0.1 mM MnCl 2 at 37 C followed by SDS-PAGE. For radiometric RNA cleavage assays, cein label were purchased from Dharmacon. Cleavage reactions were performed as described in (Gonzalez et al., 1999) .
Analytical Ultracentrifugation
Equilibrium sedimentation and data analysis was performed as described in (Dey et al., 2005) using purified Ire1 cyto prepared in 50 mM Tris-Cl (pH 7.0), 20 mM MgCl 2 , 20 mM KCl, and 0.5 mM TCEP in the absence or presence of 1 mM ADP.
Isothermal Titration Calorimetry ITC was performed using a VP-ITC calorimeter (MicroCal). 2.5 mM ADP, 100 mM Ire1 cyto , and 100 mM Ire1 cyto(D797A) were individually prepared in 50 mM Tris-Cl (pH 7.0), 150 mM NaCl, 20 mM MgCl 2 , and 2 mM DTT. The ADP solution was serially titrated into 1.35 mL of Ire1 protein solution or buffer control using 28 consecutive 10 ml injections at 240 s intervals at 20 C. Resultant binding isotherms were processed using MicroCal Origin 5.0 software. The final model was fitted to a one-site binding model.
Yeast Experiments
The entire yeast IRE1 gene including 1 kb of 5 0 and 0.3 kb of 3 0 flanking sequence was amplified by PCR and cloned between the XhoI and EagI sites of the low copy-number LEU2 vector pRS315 generating pC3059. Plasmid pC3060 was derived from pC3059 by inserting a PstI site and FLAG epitope (DYKDDDDK) immediately before the IRE1 stop codon. Plasmids pC3061-pC3067 containing the IRE1 dimer-interface mutations R697A, R697D, D732R, D730A, D730R, R697D-D730R, and D723R-R730D, respectively, were generated in pC3060 by fusion PCR. Untagged versions of the IRE1 mutants were generated by transferring an NheI-SacI fragment carrying the mutations to pC3059. The nuclease active-site mutations were transferred from the E. coli expression vectors to pC3060 generating the low copy-number LEU2 plasmids pC2994-pC2997 and pC3032-pC3036 carrying the mutations Y1043A, R1056A, N1057A, H1061A, R1053E, D995A, L1037A, Y1040A, and R1041A, respectively. Mutant plasmids were introduced into yeast strain F862 , obtained from the yeast genome deletion collection, and tested for growth on SD minimal medium supplemented with essential nutrients and 0.25 mg/ml tunicamycin.
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